chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Approximately 2-3 years post vax a pre-school pt developed chickenpox and was excluded from school. The pts brother also had a reaction following exposure to varicella virus live.
Moderna COVID-19 Vaccine EUA dizziness and weakness, lasting about 2 hr, onset about 30 min after shot
ATRIAL FIBRILLATION; This spontaneous report received from a patient concerned a 50 year old female . The patient's weight was 120 pounds, and height was 63 inches. The patient's concurrent conditions included: atrial fibrillation (first episode in MAY-2019). The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 207A21A expiry: UNKNOWN) dose was not reported, 1 total administered on 08-APR-2021 into left arm for covid-19 prophylaxis. Age at time of vaccination 50 years old. No concomitant medications were reported.  On unspecified date in APR-2021, few days later after the vaccination patient had second episode of atrial fibrillation. Patient had more episodes like heart palpitation, shortness of breath, weakness and all symptoms of atrial fibrillation. The patient had an ER (emergency room) visit on April 2021. The patient stated that she had episodes of atrial fibrillation every two weeks, which was more frequently. On an unspecified date in AUG-2022, patient had visit to cardiologist. On an unspecified date in AUG-2022, patient had an echo ultrasound on the heart and which result that the heart structure was good "heart looked normal". The physician was unable to tell what the cause was. On an unspecified date in DEC-2022, patient had visit to Electrophysiologist. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of atrial fibrillation was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20230252476-Atrial fibrillation . The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event. Specifically: MEDICAL HISTORY. Therefore, this event is considered inconsistent with vaccine administration.
This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. No information about the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant therapies was provided. On 06-JAN-2017 at 12:58, the patient was vaccinated with improperly stored VARIVAX injection (lot # M035142) (expiration date, dose and route of administration were not reported). The vaccine underwent previous temperature excursions. The number of previous excursions, time frames and values of incorrect temperature were unknown. No adverse effects were reported. Digital data logger was used. Product quality complaint was not involved. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1701USA008441: US-009507513-1704USA000389: US-009507513-1704USA000390: US-009507513-1704USA000391: US-009507513-1704USA000392: US-009507513-1704USA000393: US-009507513-1704USA000394: US-009507513-1704USA000395: US-009507513-1704USA000396: US-009507513-1704USA000397: US-009507513-1704USA000398: US-009507513-1704USA000399: US-009507513-1704USA000400: US-009507513-1704USA000401: US-009507513-1704USA000402: US-009507513-1704USA000403: US-009507513-1704USA000404: US-009507513-1704USA000405: US-009507513-1704USA000406: US-009507513-1704USA000407: US-009507513-1704USA000408: US-009507513-1704USA000409: US-009507513-1704USA000410: US-009507513-1704USA000411: US-009507513-1704USA000412: US-009507513-1704USA000413: US-009507513-1704USA000414: US-009507513-1704USA000415: US-009507513-1704USA000416: US-009507513-1704USA000417: US-009507513-1704USA000418: US-009507513-1704USA000419: US-009507513-1704USA000420: US-009507513-1704USA000421: US-009507513-1704USA000422: US-009507513-1704USA000426: US-009507513-1704USA000424: US-009507513-1704USA000425: US-009507513-1704USA000427: US-009507513-1704USA000428: US-009507513-1704USA000429: US-009507513-1704USA000430: US-009507513-1704USA000431: US-009507513-1704USA000432: US-009507513-1704USA000433: US-009507513-1704USA000434: US-009507513-1704USA000435: US-009507513-1704USA000436: US-009507513-1704USA000437: US-009507513-1704USA000438: US-009507513-1704USA000439: US-009507513-1704USA000440: US-009507513-1704USA000441: US-009507513-1704USA000442: US-009507513-1704USA000443: US-009507513-1704USA000444: US-009507513-1704USA000445: US-009507513-1704USA000446: US-009507513-1704USA000447: US-009507513-1704USA000448: US-009507513-1704USA000449: US-009507513-1704USA000450: US-009507513-1704USA000451: US-009507513-1704USA000452: US-009507513-1704USA000453: US-009507513-1704USA000454: US-009507513-1704USA000455: US-009507513-1704USA000456: US-009507513-1704USA000457.
Was given the first Moderna shot twice; Patient received second dose 23 days apart from 1st one; This spontaneous case was reported by a consumer and describes the occurrence of EXTRA DOSE ADMINISTERED (Was given the first Moderna shot twice) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received second dose 23 days apart from 1st one) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020F21A) for COVID-19 vaccination.     Concurrent medical conditions included Disability.   On 05-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Aug-2021, the patient experienced EXTRA DOSE ADMINISTERED (Was given the first Moderna shot twice) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received second dose 23 days apart from 1st one). On 28-Aug-2021, EXTRA DOSE ADMINISTERED (Was given the first Moderna shot twice) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received second dose 23 days apart from 1st one) had resolved.            No Concomitant medication information was reported.  No treatment medications were provided. Patient had no symptoms.   Most recent FOLLOW-UP information incorporated above includes: On 04-Nov-2021: Follow-up received, contains primary reporters information updated,Patient demographics, Medical history,vaccination information, event information and narrative was updated accordingly.
09/12/2021 EMERGENCY ROOM 09/13/2021 EMERGENCY ROOM 09/13/2021 ADMITTED SEVERAL TEST RAN AND SHE HAD A BLOOD CLOT AT THE BASE OF HER BRAIN BREAKING OFF CAUSING MINI STROKES. NO BLOOD CLOT EVER DETECTED BEFORE THIS EVENT. 09/20/21 SENT TO HOSPITAL FOR REHAB FOR STROKE AND CONTINUED TO GET WORSE. PATIENT COULD ONLY MOVE HER EYES NOTHING ELSE WITH HER BODY AND COULD NOT SPEAK OR EAT. 09/30/2021 GOT SENT HOME ON HOSPICE WITH 24/7 CARE 11/20/2021 DIED
First day: Dizziness, light headedness, severe joint pain, teeth pain, fatigue, irritability Second day: Swollen back of the neck at base of skull, eye pressure, fatigue.
Low grade fever noted @ "bed time" 9/3/09. Temp 102 degrees F @ 7:15am 9/4/09. Child had been given TYLENOL: Ibuprofen night before and in morning. Child began vomiting @ 8am 9/4/09. Continuing with medication, giving tepid baths: Urged to ensure adequate fluid intake.
Information has been received from a physician regarding a patient who, along with 6 other patients, in October/November 2005, was vaccinated with pneumococcal 23v polysaccharide vaccine (Lot# 650331/0749P and 649989/0579P). Some patients were first time vaccinated while others received a previous injection at least 5 years ago. Concomitantly they were vaccinated in separate sites with a dose of influenza virus vaccine  (unspecified). Subsequently, the patient developed severe local reactions.  The patient was reported as recovered.  The records of testing prior to release of this lot have been checked by Quality Assurance and found to be satisfactory. The lot complies with the standards of the Center for Biologics Evaluation and Research and was released. Additional information has been requested. In additional, a review of the Quality Control Quarantine/Rejection System revealed that there were no open Quarantines registered against this lot/fill. There was no product quality complaint involved. Additional information ahs been requested.
Approximately about 3-4 weeks after my booster shot (Dose 3) I experienced the following symptoms: Sore left shoulder, swollen feet and ankles, pain and swelling in both of my hands. I took Oxicam and extra strength Tylenol for treatment but it did not help improve my symptoms. I saw my doctor at February 23 and she ordered lab work (blood work) and by February 28 she prescribed me with prednisone and had the blood work repeated by March 8. As of today 05/19/2022 the symptoms are gone and I believe it's because of prednisone.
This spontaneous report was received from a 50 year old male patient who is a police officer. No medical history was reported. On an unknown date in late 1900 or early 2000, the patient was vaccinated with a dose of hepatitis A vaccine, inactivated (manufacturer unknown) (lot #, expiry, dose, route not reported) and had a low titer of 2 or no titer. No concomitant medications were reported. Police Officer believes he received a primary series for hepatitis A vaccine, inactivated(manufacturer unknown), boosters doses and another set of the series. Police Officer believed he received 3 complete sets of hepatitis A vaccine, inactivated(manufacturer unknown). Police Office stated in order for the police department to pay for the hepatitis A vaccine, inactivated(manufacturer unknown), the titers needed to be done to justify getting the vaccines if necessary. The outcome of low titer of 2 or no titer was unknown. This is 1 of 2 reports regarding the same patient. Additional information has been requested.
pt recv vax 15APR98 & became ill that evening w/high fever-next day contd high fever, lethargic,to MD x3 only symptomatic tx-sx include stomach cramps, fever, diarrhea, light sensitivity in eyes, hearing sensitivity, sore throat,lost 7#;
Pt is a 46-year-old female seen in consultation for Dr elevation of bilateral arm injection sites. Patient states she had influenza vaccination injections in her right arm and hepatitis A vaccination injection in her left arm on 10/3/18. Patient denies noticing any symptoms in her left arm following the injection other than a "twinge" at times. In her proximal right arm near injection site, patient noticed a knot about the size of a marble appear 3 weeks after the injection. Patient states she was prescribed a Z-Pak, which seemed to make knot go away. Patient denies drainage of the knot, but patient does report erythema of the knot at first. Patient now reports a dull constant ache in her proximal right upper extremity. Rates the pain for-5/10. Describes the pain as tenderness and soreness. Patient denies any fever, sweats, chills. Follow-up as needed.
Initial report was received 12 November 2010 from a health care professional. An 85-year-old female patient received an injection of FLUZONE HIGH-DOSE, lot number U3614AA on 03 November 2010 and two days later on 05 November 2010, she experienced a high fever of 102.3, anemia and dehydration and went to the emergency room. Outcome was not reported. No additional information was provided at the time of the report. Follow-up information was received 07 December 2010 from a health care professional who reported that the patient recovered. No additional information was provided. Follow-up information received from a health care professional on 03 January 2011 reported that the patient was seen by a physician for evaluation of weakness, leg swelling and hospital follow-up. The patient had a history of neuropathy, hypertensive heart disease, lumbar disc displacement and hypothyroidism (unspecified). The patient's concomitant medications included thiamine HCl 100 milligrams (mg) one tablet (tab) once each day, potassium chloride 10 milliequivalent (mEq) one as needed, furosemide 20 mg once tab once each day, folic acid 1 mg one tab once each day, FLOMAX 0.4 mg one tab once each day, ALDACTONE 50 mg one tab twice each day, Ted hose fit to patient, LEVOXYL 30 micrograms (mcg) one tab once each day, GERITOL complete, one daily, DIOVAN HCT Aspirin EC 81 mg one tab once each day. The patient received the FLUZONE HIGH DOSE on 03 November 2010. On 05 November she reported a fever and weakness where she was triaged and advised to go to the Emergency Room (ER). The patient had no testing performed and was not hospitalized. The etiology was reported as unknown however, was reported as possible reaction to Hi Dose influenza. The outcome was reported as recovered on 05 November 2010 after the ER visit. The patient was seen in the physician's office on 09 November 2010 for follow-up from the ER. At this time, she was afebrile in the office. Follow-up information was received from a health care professional on 18 February 2011. The patient received an intramuscular right deltoid injection of FLUZONE HIGH-DOSE. No additional information available at this time. The outcome remained recovered. Documents held by sender: None.
HPI: Patient is a * year old * who presents following administration of a single dose of J&J COVID19 vaccine in the left deltoid.  Patient states she started to experience ocular burning and tearing about 20 minutes following administration of the vaccine.  She denies ocular pain.  Patient denies wearing contacts, eye makeup, and face products at this time.  She relates that she spent most of her day outside in the sun today but has never experienced these symptoms in the past.  She reports an allergy to amoxicillin and numerous food sensitivities.  She has never required epinephrine for treatment of aforementioned allergies.  She denies a history of seasonal allergies.  She relates that she has a past medical history of PCOS.  She does not take medication on a daily basis.  She denies chest pain, difficulty breathing, swelling of the face/lips/tongue/throat, skin rash/itching, cramping abdominal pain, nausea, and vomiting.     Exam (update as needed): GEN: Alert and oriented x 4, NAD. HEAD: NCAT EYES: Conjunctival injection bilaterally.  Tearing noted in the bilateral eyes.  No purulence noted.  No foreign body noted.  Surrounding tissue nonedematous.  Visual acuity grossly intact.  PERRL, EOMI ENT: Ears normal, Nose normal, OP normal, no evidence of angioedema NECK: Supple, without LAD.  CV: RRR, no m/r/g PULM: Clear to auscultation bilaterally, no accessory muscle use ABD: Soft, no tenderness. SKIN: No rashes, skin warm and dry.  No erythema or edema of the injection site. MSK: FROM, MS 5/5 NEURO: Alert and oriented x 4, CN 2-12 grossly intact, no ataxia, gait steady   Clinical Impression/Field Tx: Possible allergic conjunctivitis, bilateral eyes.  Patient not displaying active signs or symptoms of anaphylaxis, to include facial edema and patient demonstrated ability to control airway.  No foreign body was noted in the orbi to explain symptomst, nor was purulence noted, thus decreasing likelihood of infection origin.  Visual acuity was not compromised at the time of exam.  Conjunctival injection and epiphora, in addition to consistent sun and wind exposure, makes an allergic conjunctivitis more likely.   Instructed patient to consult their PCP or follow up with urgent care regarding the post-vaccination reaction.  Also instructed patient to consult an ophthalmologist if they are able to should the eye symptoms not improve.  Recommended patient utilize visine or other normal saline eye drops for burning sensation relief, in addition to OTC antihistamine medication per package directions..  Patient instructed to go to emergency department should they develop chest pain, difficulty breathing, swelling of the face/lips/mouth/tongue/throat, or cramping abdominal pain with nausea/vomiting, as these are signs of possible anaphylaxis that requires immediate intervention.     Medications administered: None   Disposition:  Home
Rash on stomach on 2/5/14. 2/5/14 Child irritable. Wobbly gait after bath. Seen in ED ? water in ears. Same sx the next day. Possible dizziness and nausea. 2/7/14 Seen in office by Dr.
could hardly breathe; right side of chest hurt, like I pulled a muscle; dysentery; This spontaneous case was reported by a consumer and describes the occurrence of DYSENTERY (dysentery) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Blood pressure high and Blood sugar abnormal.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced DYSENTERY (dysentery) (seriousness criterion medically significant). On 31-Mar-2021, the patient experienced DYSPNOEA (could hardly breathe) and CHEST PAIN (right side of chest hurt, like I pulled a muscle). At the time of the report, DYSENTERY (dysentery), DYSPNOEA (could hardly breathe) and CHEST PAIN (right side of chest hurt, like I pulled a muscle) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products known to have been used by the patient, within two weeks prior to the event, included high blood pressure medication and medication for sugars.  Treatment of these events included unspecified ointment.  Very limited information regarding the has been provided at this time for the event. Further information has been requested.  The reported events were considered possibly related to mRNA-1273.; Sender's Comments: Very limited information regarding the has been provided at this time for the event. Further information has been requested.
Red rash, bumps  that itch appeared 4 days after, mainly on arms.
Received vaccine in the morning 08:00 am, took acetaminophen 1 GM at 09:00 am due to pain in arm.  By 10:30pm, I began having flu like symptoms, (aches, low grade fever, sinus symptoms) took another acetaminophen 1 GM.  At 11:00 pm, developed severe rigors that lasted for approximately 2 hours. I am an RN and I have seen many cases of sepsis and felt like I was experiencing similar symptomatology.   By 1:45 am, the rigors finally ceased and the body, muscle and joint pain became severe (on a pain scale of 1-10, it was an 8).    At 7:00 am, I took another acetaminophen 1 GM, the body pain became much less and I was experiencing a global headache.  I do not get headaches, so this was unusual.  By 10:00 am, the headache was minimal, body aches were gone, only sinus symptoms persisted.
2 weeks after shot sudden dizziness, intense ringing in ears, Los of hearing. Following ENT visit 50% hearing loss both ears based on hearing test. No problems with ringing or hearing loss before the shot.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67-year-old female patient (not pregnant) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 03Oct2023 as dose 1, single (Batch/Lot number: unknown) at the age of 67 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "diabetes" (unspecified if ongoing); "HPB" (unspecified if ongoing); "hypothyroidism" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Oct2023, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19. Patient treat with Paxlovid form 24Oct2023 to 28Oct2023.   The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
pt recv vax & dropped head & passed out;ammonia held under nose & pt responded by opening eyes;pt immed passed out again;lips cyanotic & hands cool & clammy to touch;appeared to clench & posture towards body;pale pulse regular & not rapid;
Information has been received from a physician via field representative referring to a patient of unknown age and gender. On an unknown date the patient was vaccinated with a dose of GARDASIL, (intramuscular, strength, dose number, lot# and dose were unknown). On an unknown date the patient experienced facial numbness after GARDASIL injection. The patient sought medical attention via phone call. The outcome of facial numbness was unknown. The relationship of facial numbness and GARDASIL was not reported. Additional information has been requested.
Breast-Feeding; Pain in the arm of the injection; Shortness of breath; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in the arm of the injection), DYSPNOEA (Shortness of breath) and MATERNAL EXPOSURE DURING BREAST FEEDING (Breast-Feeding) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced PAIN IN EXTREMITY (Pain in the arm of the injection) and DYSPNOEA (Shortness of breath). On an unknown date, the patient experienced MATERNAL EXPOSURE DURING BREAST FEEDING (Breast-Feeding). At the time of the report, PAIN IN EXTREMITY (Pain in the arm of the injection) and DYSPNOEA (Shortness of breath) outcome was unknown and MATERNAL EXPOSURE DURING BREAST FEEDING (Breast-Feeding) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications and treatment details were not reported.
About 24 hours after receiving the second COVID vaccine started to have severe chills. Since chills is a known side effect and went away in 24 hours, I took 600 mg Ibuprofen and felt better by the next day. On 02/05/2021, during the afternoon, started having some minor generalized pruritus, which I didn't treat. Early morning on 02/06/2021, around 3 a.m, I started experiencing more significant pruritus and around 7 a.m that day broke out in a maculopapular rash on trunk, arms, legs, and along hairline at back of neck. Also had enlarge lymph nodes in occipital and posterior auricular area. May have been more but didn't do a purposeful check in other areas. I treated it with H2 blocker and diphenhydramine and it resolved after 72 hours.
A 4.5 year old patient had received an intramuscular dose of MENACTRA (lot number and anatomical site of administration were not reported) on an unspecified date of August 2013. The patient had no illness or medical conditions at time of vaccination. The patient's concomitant medications were not reported. The patient was supposed to receive MMR vaccine and was inadvertently administered MENACTRA. On an unspecified date of August 2013 post vaccination, the patient had uninterruptedly slept for 17 hours. No other symptoms were reported. No laboratory tests were performed and the patient's corrective treatment was not reported. On an unspecified date the patient had recovered from event. Documents held by sender: None
1/28/2021- Seen by FNP for indigestion, chest pressure and palpitations.  EKG reviewed and referral made to Cardiology. 1/29/2021-1800 Presented to ED in cardiac arrest-onset PTA.  Patient was found unresponsive by his wife at their home.  The last known well was at 1530 when she called him on the phone.  The patient was pronounced at ~1850.
Low grade fever Mild headache Fatigue Stiff neck Edema in ankle and feet
Had shot yesterday. Today I woke up to swollen, puffy eyelids and bottom of eye. Red and itchy. Itchy area around face and scalp.